Pacira BioSciences Inc (PCRX)
29.23
+0.20
(+0.69%)
USD |
NASDAQ |
Mar 28, 16:00
29.23
0.00 (0.00%)
After-Hours: 18:26
Pacira BioSciences Cash from Investing (TTM): 77.54M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 77.54M |
September 30, 2023 | 80.36M |
June 30, 2023 | 37.18M |
March 31, 2023 | 49.02M |
December 31, 2022 | -225.18M |
September 30, 2022 | -169.46M |
June 30, 2022 | -157.02M |
March 31, 2022 | -173.14M |
December 31, 2021 | -20.79M |
September 30, 2021 | -170.02M |
June 30, 2021 | -337.80M |
March 31, 2021 | -304.70M |
December 31, 2020 | -277.61M |
September 30, 2020 | -226.08M |
June 30, 2020 | -17.61M |
March 31, 2020 | -235.54M |
December 31, 2019 | -128.49M |
September 30, 2019 | -220.86M |
June 30, 2019 | -132.02M |
March 31, 2019 | 109.35M |
December 31, 2018 | 20.58M |
September 30, 2018 | 152.44M |
June 30, 2018 | 30.50M |
March 31, 2018 | -90.22M |
December 31, 2017 | -223.76M |
Date | Value |
---|---|
September 30, 2017 | -239.38M |
June 30, 2017 | -225.22M |
March 31, 2017 | -183.72M |
December 31, 2016 | -61.75M |
September 30, 2016 | -47.54M |
June 30, 2016 | -42.96M |
March 31, 2016 | -41.33M |
December 31, 2015 | -19.26M |
September 30, 2015 | -24.25M |
June 30, 2015 | -116.69M |
March 31, 2015 | -129.25M |
December 31, 2014 | -120.43M |
September 30, 2014 | -107.52M |
June 30, 2014 | -2.719M |
March 31, 2014 | 22.33M |
December 31, 2013 | -42.94M |
September 30, 2013 | -35.80M |
June 30, 2013 | -41.22M |
March 31, 2013 | -83.24M |
December 31, 2012 | -29.52M |
September 30, 2012 | -63.65M |
June 30, 2012 | -64.40M |
March 31, 2012 | -37.82M |
December 31, 2011 | -36.12M |
September 30, 2011 | -27.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-337.80M
Minimum
Jun 2021
109.35M
Maximum
Mar 2019
-122.14M
Average
-163.24M
Median
Cash from Investing (TTM) Benchmarks
Arbutus Biopharma Corp | 50.77M |
Chimerix Inc | 70.60M |
Karyopharm Therapeutics Inc | 7.94M |
FibroGen Inc | 153.66M |
Arcutis Biotherapeutics Inc | 180.23M |